Drug Development Molecular Biology Pharma Companies Workshop 
Drug Discovery World
NOVEMBER 15, 2022
As such, the synthesis of DNA oligonucleotides for routine molecular biology applications is often outsourced to service provider companies that operate DNA synthesisers to meet these demands. . Synthetic libraries for antibody drug discovery .
Drug Discovery World
AUGUST 16, 2022
These observations may come to light in the clinic, but these disparities can be attributed to every phase of the drug development pipeline – clinical trials, translational research and, ultimately, drug discovery. . Instead, molecular markers are more accurate indicators of the patient’s associated risks. .
Expert insights. Personalized for you.
246 
Let's personalize your content